Labcorp Holdings Inc.
LH Healthcare Diagnostics & Research
Labcorp Holdings Inc.’s revenue for fiscal 2025 (year ended December 2025) was $14.0 billion, up 7.25% from fiscal 2024. In the quarter to June 2026, revenue grew 5.78%, EPS grew 28.4%, free cash flow fell 42.0% and total debt rose 15.1%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for five consecutive years, revenue growth for three.
Follow LH
Labcorp Holdings Inc. (LH) EV/FCF
As of 16 October 2026, Labcorp Holdings Inc. (LH) trades at a EV/FCF of 30.8×. Over the past ten years it has ranged from 9.1× (April 2021) to 48.9× (April 2015); the current reading is higher than 89% of that period.
EV/FCF, daily
Embed this chart
Annual newest first
| Period | EV/FCF | Change |
|---|---|---|
| FY2025 | 23.7× | (1.68%) |
| FY2024 | 24.1× | (25.59%) |
| FY2023 | 32.4× | 111.03% |
| FY2022 | 15.3× | 41.23% |
| FY2021 | 10.9× | (10.50%) |
| FY2020 | 12.1× | (37.53%) |
| FY2019 | 19.4× | 13.72% |
| FY2018 | 17.1× | 0.01% |
| FY2017 | 17.1× | (0.08%) |
| FY2016 | 17.1× | (20.87%) |
Quarterly newest first
| Period | EV/FCF | Change |
|---|---|---|
| Jun 2026 | 27.8× | 30.26% |
| Mar 2026 | 21.3× | (10.06%) |
| Dec 2025 | 23.7× | 4.06% |
| Sep 2025 | 22.8× | (2.69%) |
| 42 more quarters | Free account |
Against its own ten years
EV/FCF against peers
| Company | EV/FCF |
|---|---|
| GH Guardant Health, Inc. compare | −83.1× |
| DGX Quest Diagnostics Incorporated compare | 23.1× |
| MEDP Medpace Holdings, Inc. compare | 24.1× |
| LH Labcorp Holdings Inc. | 30.8× |
| RVTY Revvity Inc. compare | 34.0× |
| IDXX IDEXX Laboratories, Inc. compare | 36.0× |
| MTD Mettler-Toledo International, Inc. compare | 40.2× |
| ILMN Illumina, Inc. compare | 44.1× |
| WAT Waters Corporation compare | 129× |
What EV/FCF is
EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))
More on LH
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement